相关实验视频
Updated: Jan 18, 2026

08:47
Oral Health Assessment by Lay Personnel for Older Adults
Published on: February 2, 2020
13.4K
年龄友好的老年医疗评估
American family physician
|January 16, 2026
概括
家庭医生越来越多地照顾老年人. 4M框架 (重要的是什么,药物,思维,移动性) 指导全面的老年医学评估,解决患者的优先事项,药物审查,认知功能和跌倒风险.
科学领域:
- 老年医学 老年医学
- 主要护理是指初级护理.
- 内部医学 内部医学
背景情况:
- 美国人口正在老龄化,在初级保健机构中,老年人 (65岁以上) 的患病率正在增加.
- 有效的老年医疗评估对于管理这一人口群体复杂的健康需求至关重要.
研究的目的:
- 将4M框架概述为老年医疗评估的结构化方法.
- 强调在初级保健中评估老年成人患者的关键组成部分.
主要方法:
- 4M框架包括:重要的事情 (患者优先级),药物 (审查和和解),思维 (认知和情绪评估) 和流动性 (跌倒风险查).
- 提到的具体工具包括用于思维的Mini-Cog和用于移动的Stopping Elderly Accidents, Deaths, and Injuries (STEADI) 等.
- 评估应促使进一步评估和干预发现的问题.
主要成果:
- 4M框架提供了对老年护理的综合方法.
- 解决患者的优先事项,优化药物,评估认知和情绪,评估移动性是必不可少的组成部分.
结论:
- 4Ms框架为家庭医生提供了一种实用和有效的模型,用于进行老年病评估.
- 这种系统的方法可以通过解决老年人健康和福祉的关键方面来提高老年人护理的质量.
相关概念视频
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
229
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
229
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197

